To investigate the effects and mechanisms of Jiangzhi Ruanmai Formula (JZRM) on atherosclerosis, specifically focusing on its impact on cholesterol metabolism and gut microbiota.
Key Findings:
JZRM significantly reduced lipid, glucose, and inflammation levels in mice, with specific reductions in serum lipid levels by X% (insert specific data).
JZRM decreased total bile acid levels in liver, intestine, and feces, and reduced aortic plaque area by Y% (insert specific data).
JZRM increased the abundance and diversity of intestinal flora, particularly enhancing beneficial bacteria.
JZRM upregulated protein expression of ABCA1, ABCG1, PPARγ, and LXRα, indicating enhanced cholesterol transport.
JZRM regulated bile acid metabolism and promoted bile acid synthesis through the FXR/CYP7A1 pathway, contributing to its therapeutic effects.
Interpretation:
JZRM regulates the gut microbiota-liver-cholesterol axis, promoting cholesterol synthesis and metabolism to alleviate atherosclerosis, suggesting a potential therapeutic strategy for cardiovascular diseases.
Limitations:
The study did not explore long-term effects of JZRM on atherosclerosis.
The sample size may limit the generalizability of the findings.
Conclusion:
JZRM shows potential in mitigating atherosclerosis through modulation of cholesterol metabolism and gut microbiota.
